> top > docs > PubMed:1312543 > annotations

PubMed:1312543 JSONTXT

Annnotations TAB JSON ListView MergeView

sentences

Id Subject Object Predicate Lexical cue
TextSentencer_T1 0-53 Sentence denotes Mineralocorticoid effector mechanism in preeclampsia.
TextSentencer_T2 54-352 Sentence denotes Mineralocorticoid effector mechanisms were evaluated in 29 patients with preeclampsia and in 25 uncomplicated pregnancies by measurement of plasma aldosterone, levels of mineralocorticoid receptor (MR) in mononuclear leucocytes, and subtraction potential difference (SPD; rectal minus oral values).
TextSentencer_T3 353-603 Sentence denotes Mean values for plasma aldosterone were not different between the two groups, but significant differences were observed for MR (preeclampsia, 81 +/- 44 receptors/cell; controls, 306 +/- 168) and SPD (preeclampsia, 65 +/- 7 mV; controls, 12 +/- 5 mV).
TextSentencer_T4 604-728 Sentence denotes In six cases we determined MR, plasma aldosterone, and SPD in patients with preeclampsia before and 3 months after delivery.
TextSentencer_T5 729-907 Sentence denotes MR were reduced before delivery (96 +/- 27 receptors/cell), and SPD increased (64 +/- 8 mV), with both parameters normalizing after delivery (MR, 242 +/- 79; SPD, 14.0 +/- 4 mV).
TextSentencer_T6 908-980 Sentence denotes Aldosterone levels returned to normal nonpregnant values after delivery.
TextSentencer_T7 981-1153 Sentence denotes These data suggest an important role for abnormalities in mineralocorticoid effector mechanisms in the etiology of preeclampsia and could be an useful marker for diagnosis.
T1 0-53 Sentence denotes Mineralocorticoid effector mechanism in preeclampsia.
T2 54-352 Sentence denotes Mineralocorticoid effector mechanisms were evaluated in 29 patients with preeclampsia and in 25 uncomplicated pregnancies by measurement of plasma aldosterone, levels of mineralocorticoid receptor (MR) in mononuclear leucocytes, and subtraction potential difference (SPD; rectal minus oral values).
T3 353-603 Sentence denotes Mean values for plasma aldosterone were not different between the two groups, but significant differences were observed for MR (preeclampsia, 81 +/- 44 receptors/cell; controls, 306 +/- 168) and SPD (preeclampsia, 65 +/- 7 mV; controls, 12 +/- 5 mV).
T4 604-728 Sentence denotes In six cases we determined MR, plasma aldosterone, and SPD in patients with preeclampsia before and 3 months after delivery.
T5 729-907 Sentence denotes MR were reduced before delivery (96 +/- 27 receptors/cell), and SPD increased (64 +/- 8 mV), with both parameters normalizing after delivery (MR, 242 +/- 79; SPD, 14.0 +/- 4 mV).
T6 908-980 Sentence denotes Aldosterone levels returned to normal nonpregnant values after delivery.
T7 981-1153 Sentence denotes These data suggest an important role for abnormalities in mineralocorticoid effector mechanisms in the etiology of preeclampsia and could be an useful marker for diagnosis.

jnlpba-st-training

Id Subject Object Predicate Lexical cue
T1 224-250 protein denotes mineralocorticoid receptor
T2 252-254 protein denotes MR
T3 259-281 cell_type denotes mononuclear leucocytes
T4 477-479 protein denotes MR
T5 631-633 protein denotes MR
T6 729-731 protein denotes MR
T7 871-873 protein denotes MR

Preeclampsia

Id Subject Object Predicate Lexical cue
PD-Preeclampsia-B_T1 40-52 ORPHA:275555 denotes preeclampsia
PD-Preeclampsia-B_T2 127-139 ORPHA:275555 denotes preeclampsia
PD-Preeclampsia-B_T3 481-493 ORPHA:275555 denotes preeclampsia
PD-Preeclampsia-B_T4 553-565 ORPHA:275555 denotes preeclampsia
PD-Preeclampsia-B_T5 680-692 ORPHA:275555 denotes preeclampsia
PD-Preeclampsia-B_T6 1096-1108 ORPHA:275555 denotes preeclampsia

Preeclampsia-compare

Id Subject Object Predicate Lexical cue
PD-Preeclampsia-B_T1 40-52 ORPHA:275555 denotes preeclampsia
PD-Preeclampsia-B_T2 127-139 ORPHA:275555 denotes preeclampsia
PD-Preeclampsia-B_T3 481-493 ORPHA:275555 denotes preeclampsia
PD-Preeclampsia-B_T4 553-565 ORPHA:275555 denotes preeclampsia
PD-Preeclampsia-B_T5 680-692 ORPHA:275555 denotes preeclampsia
PD-Preeclampsia-B_T6 1096-1108 ORPHA:275555 denotes preeclampsia

pubmed-sentences-benchmark

Id Subject Object Predicate Lexical cue
S1 0-53 Sentence denotes Mineralocorticoid effector mechanism in preeclampsia.
S2 54-352 Sentence denotes Mineralocorticoid effector mechanisms were evaluated in 29 patients with preeclampsia and in 25 uncomplicated pregnancies by measurement of plasma aldosterone, levels of mineralocorticoid receptor (MR) in mononuclear leucocytes, and subtraction potential difference (SPD; rectal minus oral values).
S3 353-603 Sentence denotes Mean values for plasma aldosterone were not different between the two groups, but significant differences were observed for MR (preeclampsia, 81 +/- 44 receptors/cell; controls, 306 +/- 168) and SPD (preeclampsia, 65 +/- 7 mV; controls, 12 +/- 5 mV).
S4 604-728 Sentence denotes In six cases we determined MR, plasma aldosterone, and SPD in patients with preeclampsia before and 3 months after delivery.
S5 729-907 Sentence denotes MR were reduced before delivery (96 +/- 27 receptors/cell), and SPD increased (64 +/- 8 mV), with both parameters normalizing after delivery (MR, 242 +/- 79; SPD, 14.0 +/- 4 mV).
S6 908-980 Sentence denotes Aldosterone levels returned to normal nonpregnant values after delivery.
S7 981-1153 Sentence denotes These data suggest an important role for abnormalities in mineralocorticoid effector mechanisms in the etiology of preeclampsia and could be an useful marker for diagnosis.

genia-medco-coref

Id Subject Object Predicate Lexical cue
C1 0-36 NP denotes Mineralocorticoid effector mechanism
C2 40-52 NP denotes preeclampsia
C3 54-91 NP denotes Mineralocorticoid effector mechanisms
C6 127-139 NP denotes preeclampsia
C5 110-139 NP denotes 29 patients with preeclampsia
C7 147-175 NP denotes 25 uncomplicated pregnancies
C4 110-175 NP denotes 29 patients with preeclampsia and in 25 uncomplicated pregnancies
C8 194-212 NP denotes plasma aldosterone
C10 224-255 NP denotes mineralocorticoid receptor (MR)
C11 287-319 NP denotes subtraction potential difference
C9 214-319 NP denotes levels of mineralocorticoid receptor (MR) in mononuclear leucocytes, and subtraction potential difference
C12 321-324 NP denotes SPD
C13 369-387 NP denotes plasma aldosterone
C14 415-429 NP denotes the two groups
C15 477-479 NP denotes MR
C16 481-493 NP denotes preeclampsia
C17 521-529 NP denotes controls
C18 548-551 NP denotes SPD
C19 553-565 NP denotes preeclampsia
C20 580-588 NP denotes controls
C21 631-633 NP denotes MR
C22 635-653 NP denotes plasma aldosterone
C23 659-662 NP denotes SPD
C25 680-692 NP denotes preeclampsia
C24 666-692 NP denotes patients with preeclampsia
C26 729-731 NP denotes MR
C27 793-796 NP denotes SPD
C28 827-842 NP denotes both parameters
C29 871-873 NP denotes MR
C30 887-890 NP denotes SPD
C31 908-926 NP denotes Aldosterone levels
C32 1039-1076 NP denotes mineralocorticoid effector mechanisms
C33 1096-1108 NP denotes preeclampsia
R1 C3 C1 coref-ident Mineralocorticoid effector mechanisms,Mineralocorticoid effector mechanism
R2 C6 C2 coref-ident preeclampsia,preeclampsia
R3 C12 C11 coref-ident SPD,subtraction potential difference
R4 C13 C8 coref-ident plasma aldosterone,plasma aldosterone
R5 C14 C4 coref-ident the two groups,29 patients with preeclampsia and in 25 uncomplicated pregnancies
R6 C15 C10 coref-ident MR,mineralocorticoid receptor (MR)
R7 C16 C6 coref-ident preeclampsia,preeclampsia
R8 C17 C7 coref-ident controls,25 uncomplicated pregnancies
R9 C18 C12 coref-ident SPD,SPD
R10 C19 C16 coref-ident preeclampsia,preeclampsia
R11 C20 C17 coref-ident controls,controls
R12 C21 C15 coref-ident MR,MR
R13 C22 C13 coref-ident plasma aldosterone,plasma aldosterone
R14 C23 C18 coref-ident SPD,SPD
R15 C25 C19 coref-ident preeclampsia,preeclampsia
R16 C24 C5 coref-ident patients with preeclampsia,29 patients with preeclampsia
R17 C26 C21 coref-ident MR,MR
R18 C27 C23 coref-ident SPD,SPD
R19 C28 C9 coref-ident both parameters,"levels of mineralocorticoid receptor (MR) in mononuclear leucocytes, and subtraction potential difference"
R20 C29 C26 coref-ident MR,MR
R21 C30 C27 coref-ident SPD,SPD
R22 C31 C22 coref-other Aldosterone levels,plasma aldosterone
R23 C32 C3 coref-ident mineralocorticoid effector mechanisms,Mineralocorticoid effector mechanisms
R24 C33 C25 coref-ident preeclampsia,preeclampsia

GENIAcorpus

Id Subject Object Predicate Lexical cue
T1 0-36 other_name denotes Mineralocorticoid effector mechanism
T2 40-52 other_name denotes preeclampsia
T3 54-91 other_name denotes Mineralocorticoid effector mechanisms
T4 113-121 multi_cell denotes patients
T5 127-139 other_name denotes preeclampsia
T6 150-175 other_name denotes uncomplicated pregnancies
T7 194-212 lipid denotes plasma aldosterone
T8 224-250 protein_family_or_group denotes mineralocorticoid receptor
T9 252-254 protein_family_or_group denotes MR
T10 259-281 cell_type denotes mononuclear leucocytes
T11 287-319 other_name denotes subtraction potential difference
T12 321-324 other_name denotes SPD
T13 326-350 other_name denotes rectal minus oral values
T14 369-387 lipid denotes plasma aldosterone
T15 477-479 protein_family_or_group denotes MR
T16 481-493 other_name denotes preeclampsia
T17 548-551 other_name denotes SPD
T18 553-565 other_name denotes preeclampsia
T19 631-633 protein_family_or_group denotes MR
T20 635-653 lipid denotes plasma aldosterone
T21 659-662 other_name denotes SPD
T22 666-674 multi_cell denotes patients
T23 680-692 other_name denotes preeclampsia
T24 719-727 other_name denotes delivery
T25 729-731 protein_family_or_group denotes MR
T26 752-760 other_name denotes delivery
T27 793-796 other_name denotes SPD
T28 861-869 other_name denotes delivery
T29 871-873 protein_family_or_group denotes MR
T30 887-890 other_name denotes SPD
T31 908-919 lipid denotes Aldosterone
T32 939-964 other_name denotes normal nonpregnant values
T33 971-979 other_name denotes delivery
T34 1022-1035 other_name denotes abnormalities
T35 1096-1108 other_name denotes preeclampsia
T36 1143-1152 other_name denotes diagnosis